• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comparative in vitro study of teichomycin A2.替考霉素A2的体外比较研究。
Antimicrob Agents Chemother. 1983 Mar;23(3):497-9. doi: 10.1128/AAC.23.3.497.
2
In vitro activity of teichomycin compared with those of other antibiotics.替考霉素与其他抗生素的体外活性比较。
Antimicrob Agents Chemother. 1983 Sep;24(3):425-8. doi: 10.1128/AAC.24.3.425.
3
In vitro activity of teichomycin against isolates of gram-positive bacteria.
Chemotherapy. 1983;29(4):275-82. doi: 10.1159/000238209.
4
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.替考拉宁与万古霉素单独及联合利福平、氨基糖苷类药物对葡萄球菌和肠球菌的体外比较活性
Antimicrob Agents Chemother. 1984 Apr;25(4):411-2. doi: 10.1128/AAC.25.4.411.
5
Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.替考霉素：与其他抗生素相比的体外和体内评价
J Antimicrob Chemother. 1983 May;11(5):419-25. doi: 10.1093/jac/11.5.419.
6
Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.替考霉素A2与万古霉素对葡萄球菌和肠球菌的体外活性比较。
Antimicrob Agents Chemother. 1982 Mar;21(3):504-5. doi: 10.1128/AAC.21.3.504.
7
In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.替考霉素A2与青霉素和万古霉素相比对革兰氏阳性球菌的体外活性。
Eur J Clin Microbiol. 1982 Oct;1(5):278-81. doi: 10.1007/BF02019971.
8
In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.替考拉宁和万古霉素单独及与利福平联合使用时的体外活性。
Antimicrob Agents Chemother. 1983 Mar;23(3):402-6. doi: 10.1128/AAC.23.3.402.
9
Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroids.替考拉宁与其他抗生素对JK类白喉杆菌的体外活性比较
Antimicrob Agents Chemother. 1983 Aug;24(2):145-6. doi: 10.1128/AAC.24.2.145.
10
Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
Chemioterapia. 1988 Feb;7(1):20-3.

引用本文的文献

1
Coagulase-negative staphylococci.凝固酶阴性葡萄球菌
Clin Microbiol Rev. 2014 Oct;27(4):870-926. doi: 10.1128/CMR.00109-13.
2
[Perioperative cefamandole prevention in aortocoronary bypass operations: the course of serum levels in extracorporeal circulation].
Langenbecks Arch Chir. 1984;362(4):237-43. doi: 10.1007/BF01254650.
3
In vitro activity and human pharmacokinetics of teicoplanin.替考拉宁的体外活性及人体药代动力学
Antimicrob Agents Chemother. 1984 Dec;26(6):881-6. doi: 10.1128/AAC.26.6.881.
4
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.替考拉宁与萘夫西林及万古霉素治疗由甲氧西林敏感或耐药金黄色葡萄球菌引起的实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1984 Jul;26(1):61-4. doi: 10.1128/AAC.26.1.61.
5
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.替考拉宁与万古霉素单独及联合利福平、氨基糖苷类药物对葡萄球菌和肠球菌的体外比较活性
Antimicrob Agents Chemother. 1984 Apr;25(4):411-2. doi: 10.1128/AAC.25.4.411.
6
In vitro activity of teichomycin compared with those of other antibiotics.替考霉素与其他抗生素的体外活性比较。
Antimicrob Agents Chemother. 1983 Sep;24(3):425-8. doi: 10.1128/AAC.24.3.425.
7
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
8
Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.替考拉宁治疗严重革兰氏阳性菌感染的疗效、药代动力学及安全性的临床评估
Antimicrob Agents Chemother. 1987 Feb;31(2):207-12. doi: 10.1128/AAC.31.2.207.
9
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.替考拉宁治疗革兰氏阳性菌所致严重感染的临床评价
Antimicrob Agents Chemother. 1986 Jan;29(1):52-7. doi: 10.1128/AAC.29.1.52.
10
Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
Infection. 1989 May-Jun;17(3):177-81. doi: 10.1007/BF01644026.

本文引用的文献

1
Bacteremia due to Staphylococcus aureus in patients with cancer: report on 45 cases in adults and review of the literature.
Rev Infect Dis. 1982 Jan-Feb;4(1):1-12. doi: 10.1093/clinids/4.1.1.
2
Comparative in vitro study of SQ26,776.SQ26,776的体外对比研究。
Antimicrob Agents Chemother. 1982 Feb;21(2):294-8. doi: 10.1128/AAC.21.2.294.
3
Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.替考霉素A2与万古霉素对葡萄球菌和肠球菌的体外活性比较。
Antimicrob Agents Chemother. 1982 Mar;21(3):504-5. doi: 10.1128/AAC.21.3.504.
4
Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.β-内酰胺类抗生素单独使用或与庆大霉素联合使用，用于治疗中性粒细胞减少患者的革兰氏阴性杆菌感染。
Am J Med Sci. 1976 Mar-Apr;271(2):179-86. doi: 10.1097/00000441-197603000-00006.
5
Increasing incidence of Gram-positive sepsis in cancer patients.
Med Pediatr Oncol. 1978;5(1):241-4. doi: 10.1002/mpo.2950050133.
6
Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.替考霉素，来自新放线菌（新种）的新型抗生素。I. 产生菌的描述、发酵研究及生物学特性
J Antibiot (Tokyo). 1978 Apr;31(4):276-83. doi: 10.7164/antibiotics.31.276.
7
Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.替考霉素，来自新种替考游动放线菌的新型抗生素。II. 提取与化学特性分析。
J Antibiot (Tokyo). 1978 Mar;31(3):170-7. doi: 10.7164/antibiotics.31.170.
8
Bacteremia due to gram-positive cocci in patients with neoplastic disease.
Am J Med. 1979 Apr;66(4):596-602. doi: 10.1016/0002-9343(79)91169-0.

替考霉素A2的体外比较研究。

Comparative in vitro study of teichomycin A2.

作者信息

Fainstein V, LeBlanc B, Bodey G P

出版信息

Antimicrob Agents Chemother. 1983 Mar;23(3):497-9. doi: 10.1128/AAC.23.3.497.

DOI:10.1128/AAC.23.3.497
PMID:6221695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC184679/
Abstract

Teichomycin A2 was evaluated in vitro against clinical isolates, and its activity was compared with that of other antibiotics. This compound was very active against all organisms tested; its activity was comparable to that of vancomycin, and it was superior to several other antibiotics when tested against gram-positive cocci. Because of its in vitro activity, it deserves clinical evaluation.

摘要

对替考霉素A2进行了针对临床分离株的体外评估，并将其活性与其他抗生素进行了比较。该化合物对所有测试的生物体都具有很高的活性；其活性与万古霉素相当，并且在针对革兰氏阳性球菌进行测试时优于其他几种抗生素。由于其体外活性，它值得进行临床评估。